menu
    • menu

    Company profile for Neurizon Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neurizon is a biotechnology company focused on the development of innovative solutions in the field of neurology. The company specializes in research and therapeutic products aimed at improving the treatment of neurological diseases, leveraging advanced scientific insights and cutting-edge technologies. With a commitment to enhancing patient outcomes and addressing critical medical needs, Neurizon's work is driven by a deep ...
    Neurizon is a biotechnology company focused on the development of innovative solutions in the field of neurology. The company specializes in research and therapeutic products aimed at improving the treatment of neurological diseases, leveraging advanced scientific insights and cutting-edge technologies. With a commitment to enhancing patient outcomes and addressing critical medical needs, Neurizon's work is driven by a deep understanding of the complexities of the brain and nervous system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neurizon TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 4, 96-100 Albert Road South Melbourne, VIC 3205
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurizon.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Clears NUZ-001 For Entry Into HEALEY ALS Platform Trial
    FDA Clears NUZ-001 For Entry Into HEALEY ALS Platform Trial

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-clears-nuz-001-for-entry-into-healey-als-platform-trial-302639638.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Elanco Executive Appointed As Neurizon's Board Observer
    Elanco Executive Appointed As Neurizon's Board Observer

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elanco-executive-appointed-as-neurizons-board-observer-302627190.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    FDA Lifts Clinical Hold On NUZ-001
    FDA Lifts Clinical Hold On NUZ-001

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-lifts-clinical-hold-on-nuz-001-302575595.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Neurizon Enters into Global License with Elanco for NUZ-001
    Neurizon Enters into Global License with Elanco for NUZ-001

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurizon-enters-into-global-license-with-elanco-to-accelerate-commercialisation-of-nuz-001-302497328.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share
    Neurizon Adds Strategic Regulatory and Scientific Leadership
    Neurizon Adds Strategic Regulatory and Scientific Leadership

    17 Apr 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/neurizon-adds-strategic-regulatory-and-scientific-leadership/

    CONTRACTPHARMA
    17 Apr 2025
    Share Share
    Neurizon Files IND for HEALEY ALS Platform Trial
    Neurizon Files IND for HEALEY ALS Platform Trial

    18 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurizon-files-ind-application-to-support-healey-als-platform-trial-302334407.html

    PR NEWSWIRE
    18 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search